Financials
- Market Capitalization 506.81 M
- Employee 87
- Founded N/A
- CEO N/A
- Website www.editasmedicine.com
- Headquarter Delaware, United States
- FIGI BBG005MX5GZ2
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.14
Rapporto prezzo/fatturato
4.49
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2891 | KYTX Kyverna Therapeutics, Inc. - Common Stock | 8.64 USD | +0.35% | +4.85% | +15.20% | +121.54% | 534.33 M USD | ||
| 2892 | ENTX Entera Bio Ltd. - Ordinary Shares | 3.08 USD | -3.45% | -4.35% | -4.35% | +54.00% | 533.28 M USD | ||
| 2915 | PRLD Prelude Therapeutics Incorporated - Common Stock | 6.34 USD | -3.35% | -3.35% | +36.64% | +391.47% | 505.95 M USD | ||
| 2918 | CCCC C4 Therapeutics, Inc. - Common Stock | 4.10 USD | -3.30% | 0.00% | +18.84% | +62.06% | 504.40 M USD |